1. Home
  2. EFXT vs PHAR Comparison

EFXT vs PHAR Comparison

Compare EFXT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFXT
  • PHAR
  • Stock Information
  • Founded
  • EFXT 1980
  • PHAR 1988
  • Country
  • EFXT Canada
  • PHAR Netherlands
  • Employees
  • EFXT 4800
  • PHAR N/A
  • Industry
  • EFXT Meat/Poultry/Fish
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFXT Consumer Staples
  • PHAR Health Care
  • Exchange
  • EFXT Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • EFXT 1.3B
  • PHAR 679.0M
  • IPO Year
  • EFXT N/A
  • PHAR N/A
  • Fundamental
  • Price
  • EFXT $10.47
  • PHAR $9.55
  • Analyst Decision
  • EFXT Buy
  • PHAR Strong Buy
  • Analyst Count
  • EFXT 1
  • PHAR 3
  • Target Price
  • EFXT $12.00
  • PHAR $27.00
  • AVG Volume (30 Days)
  • EFXT 510.9K
  • PHAR 5.4K
  • Earning Date
  • EFXT 02-27-2025
  • PHAR 03-13-2025
  • Dividend Yield
  • EFXT 0.52%
  • PHAR N/A
  • EPS Growth
  • EFXT N/A
  • PHAR N/A
  • EPS
  • EFXT N/A
  • PHAR N/A
  • Revenue
  • EFXT $2,424,645,961.00
  • PHAR $285,745,000.00
  • Revenue This Year
  • EFXT N/A
  • PHAR $20.08
  • Revenue Next Year
  • EFXT N/A
  • PHAR $9.22
  • P/E Ratio
  • EFXT N/A
  • PHAR N/A
  • Revenue Growth
  • EFXT 6.39
  • PHAR 30.64
  • 52 Week Low
  • EFXT $4.60
  • PHAR $6.65
  • 52 Week High
  • EFXT $10.61
  • PHAR $13.20
  • Technical
  • Relative Strength Index (RSI)
  • EFXT 64.73
  • PHAR 50.97
  • Support Level
  • EFXT $9.98
  • PHAR $9.37
  • Resistance Level
  • EFXT $10.43
  • PHAR $10.01
  • Average True Range (ATR)
  • EFXT 0.34
  • PHAR 0.52
  • MACD
  • EFXT -0.02
  • PHAR -0.10
  • Stochastic Oscillator
  • EFXT 84.20
  • PHAR 28.08

About EFXT Enerflex Ltd

Enerflex Ltd engineers, designs, manufactures and provides aftermarket support for equipment, systems, and turnkey facilities used to process and move natural gas from the wellhead to the pipeline. The company's focus is gas compression, where it offers a range of applications and gas inlet streams, from low-horsepower/low-pressure applications such as coal seam gas and solution gas vapor recovery units to high-horsepower, centralized field, or processing plant compression. Enerflex operates three business segments: North America, Latin America, Eastern Hemisphere. Each regional business segment has three main product lines: Engineered Systems, After‐market Service, and Energy Infrastructure. The North America segment earns the majority of the revenue.

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Share on Social Networks: